The Effects of Nanomicelles Curcumin on Glycemic Control, Serum Lipid Profile ,Blood Pressure and Anthropometric Measurements in Patients With Metabolic Syndrome
The Effects of Nanomicelles Curcumin on Glycemic Control, Serum Lipid Profile ,Blood Pressure and Anthropometric Measurements in Patients With Metabolic Syndrome
Metabolic syndrome is a condition which is recognized by abdominal obesity, dyslipidemia,
 hyperglycemia, and hypertension. Curcumin has beneficial effects such as antioxidant and
 anti-inflammatory effects. nanomcielle curcumin will be used in this study because of the low
 bioavailability , fast metabolism and low absorption of curcumin powder. Therefore, this
 study is planned to determine the effects of supplementation of nanomicelle curcumin on
 glycemic control, serum lipid profile ,blood pressure and anthropometric measurements in
 patients with metabolic syndrome.
Inclusion Criteria:

 -  25<body mass index >40

 -  waist circumference >102 cm in men or >88 cm in women

 -  Fasting blood glucose >100 mg/dL

 -  Triglycerides (TG) > 150 mg/dL

 -  High density lipoprotein cholesterol (HDL-C) <50 in women or <40 in men

 -  Systolic blood pressure (SBP) >130 mmHg and diastolic blood pressure (DBP) >85mmHg

 Exclusion Criteria:

 -  insulin administration for diabetes control

 -  hypo- or hyperthyroidism,

 -  renal failure or other chronic diseases

 -  pregnancy and breastfeeding

 -  taking weight loss supplements and obeying unusual weight loss plans